![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 20, 2013 11:22:06 AM
1) Stockholders equity of $5 million
2) Market value of publicly held shares of $15 million (not yet met)
3) Operating history of 2 years
4) Publicly held shares of 1 million
5) Shareholders of 300
6) Market makers = 3
7) Bid price of $4 or Closing price of $3*
*Since the bid has dropped below $4 during the application process (still in the process since #2 has not been met), the closing price of $3+ is now applicable. For #7 to be satisfied the closing price must stay above $3 for 5 consecutive business days AND muscle pharm must meet 1 of 3 conditions, 1 being an average revenues of $6 million over 3 years.
The only thing I can draw from this is that once the offering is complete, muscle pharm will be able to uplist because they'd then be meeting #2 and thus all conditions are met.
There is no mention of 45 days in the listing requirements.
There's also corporate governance requirements, but I believe all those have been met.
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM
Southern Silver Announces Updated PEA on Cerro Las Minitas: US$501M After-tax NPV5%; 21% IRR; 48 Month payback • SSV • Jun 11, 2024 5:26 AM
Swifty Global Announces South African Gambling License Approval • DRCR • Jun 10, 2024 9:15 AM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM